Article

Dopamine D2 Receptor Signaling Attenuates Acinar Cell Necroptosis in Acute Pancreatitis…

Oxidative Medicine and Cellular Longevity · 2022 · Zengkai Wu, author Xiao Han, author Jingpiao Bao, author Bin Li, author Jie Shen, author Pengli Song, author Qi Peng, author Xingpeng Wang, author Guoyong Hu, author Aristidis S. Veskoukis, Academic Editor

Key facts

Title Dopamine D2 Receptor Signaling Attenuates Acinar Cell Necroptosis in Acute Pancreatitis through the Cathepsin B/TFAM/ROS Pathway
First author Zengkai Wu, author Xiao Han, author Jingpiao Bao, author Bin Li, author Jie Shen, author Pengli Song, author Qi Peng, author Xingpeng Wang, author Guoyong Hu, author Aristidis S. Veskoukis, Academic Editor
Journal Oxidative Medicine and Cellular Longevity
Published Jan 4, 2022
DOI 10.1155/2022/4499219
Devices mentioned BK110039, K000921, K001344, K002376, K003412, K003796, K010201, K011963, K012337, K012340, K024017, K103302 and 6 more
Product codes mentioned CFR, CIG, CIT, CJO, DCN, DER, DIH, GKL, GKZ, JGS, JMO, LFX and 7 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature